ArticleMethods in molecular biology (Clifton, N.J.)2025
Allogeneic Mouse Models of Graft-Versus-Host Disease.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and Safety of Donor Lymphocyte Infusion After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.European journal of haematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graft-versus-host disease (GVHD) is a serious and potentially fatal complication that occurs after allogeneic hematopoietic cell transplantation. It is characterized by the immune response of the graft (from the donor) against the tissue of host (recipient), resulting in damage to target organs such as the skin, liver, and intestines. Understanding the underlying mechanisms of GVHD is crucial for improving treatment and prevention strategies for this debilitating condition. Animal experimental models play a key role in this process, allowing for the investigation of immune mechanisms and the evaluation of new therapies. These models provide valuable insights into the pathophysiology of GVHD and help develop more effective therapeutic approaches to improve clinical outcomes in transplant patients. In this chapter, we provide a brief overview of allogeneic and semi-allogeneic models of GVHD in mice. Then, we will address the step-by-step process for inducing experimental GVHD in mice using an allogeneic model in mice with total body irradiation myeloablation.
Indexed as
Identifiers
40100596What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.